Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT‐based radiomics signature

BACKGROUND: Tumor mutation burden (TMB) is an important determinant and biomarker for response of targeted therapy and prognosis in patients with lung cancer. The present study aimed to determine whether radiomics signature could non‐invasively predict the TMB status and driver mutations in patients...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Thorac Cancer
Prif Awduron: Wang, Xiaoxiao, Kong, Cheng, Xu, Weizhang, Yang, Sheng, Shi, Dan, Zhang, Jingyuan, Du, Mulong, Wang, Siwei, Bai, Yongkang, Zhang, Te, Chen, Zeng, Ma, Zhifei, Wang, Jie, Dong, Gaochao, Sun, Mengting, Yin, Rong, Chen, Feng
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons Australia, Ltd 2019
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6775017/
https://ncbi.nlm.nih.gov/pubmed/31414580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13163
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg